Join BOPA
Back to news articles

BCS/BCOS/UCLH Cancer Academy Cardio-Oncology Course, 11 November 2024, Royal College of Physicians, London

By BOPA Committee on 11th September 2024

This joint British Cardiovascular Society, British Cardio-Oncology Society and University College London Hospitals Cancer Academy course provides an update in contemporary cardio-oncology practice and will cover recent updates in cardio-oncology. A multidisciplinary practical approach to common cardiac issues in oncology/haem-oncology patients will be explored. For the first time, dedicated sessions for oncologists and for haematologists will be incorporated into the day.

For further information and to register (£30 fee for pharmacists), click here

BCS/BCOS/UCLH Cancer Academy Cardio-Oncology Course 2024 – BOPA

 

Latest News

By BOPA Executive Committee on 4th November 2025

Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…

Read article
By Jennifer Allen - LCC Lead on 4th November 2025

BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…

Read article
By BOPA Executive Committee on 3rd November 2025

BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…

Read article
By BOPA IOSIG on 1st November 2025

IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…

Read article